Clinical study of pancuronium bromide as a neuromuscular blocking agent in anaesthesia.
D000328:Adult; D000731:Androstanes / Q000494:pharmacology*; D000758:Anesthesia; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007267:Injections; D007540:Isonipecotic Acids / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000494:pharmacology; D013390:Succinylcholine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D013874:Thiopental
D000731:Androstanes; D007540:Isonipecotic Acids; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D001285:Atropine; D008614:Meperidine; D013390:Succinylcholine; D010197:Pancuronium; D013874:Thiopental